—
Arizona State University Skysong Innovation Center, AZ
Healthcare Data Analytics
How are small and medium-sized companies differentiating themselves with niche solutions?
Patient Monitoring Opportunities
Are you leveraging the "monitoring as a service" business model to achieve growth?
Top Imperatives in the Healthcare IT Industry
How are alternative care sites and partnerships influencing your growth strategies?
AI-Enabled Medical Imaging Industry
Are you leveraging AI tools to enhance administrative processes and patient information systems?
Innovations in the Biopsy Industry
How are early-stage robotic biopsy systems improving needle placement accuracy?
Cardiovascular Diseases
How are enabling technologies contributing to the development of more effective treatments?
Lab Automation and Monitoring Solutions
How are partnerships with in vitro diagnostics vendors helping labs optimize access and productivity?
AI-Based Drug Repurposing Industry
What are the main advantages of AI-based drug repurposing over traditional drug discovery?
Emerging Technologies in Pharmaceutical Manufacturing: Modular and Automated Platforms
In the ever-evolving landscape of pharmaceutical manufacturing, modular and automated platforms are spearheading a transformative shift, particularly in the realm of non-biologics.
As global demand for non-biologics surges, the pharmaceutical sector is increasingly turning to these advanced technologies to meet regulatory standards, enhance productivity, and reduce waste.
The rise of Pharma 4.0, characterized by the integration of AI, the Internet of Things (IoT), and big data analytics, is playing a pivotal role in this revolution.
Key Megatrends in MedTech R&D Investments: Innovating Healthcare Solutions
The landscape of medical technology (MedTech) is evolving rapidly, driven by significant investments in research and development (R&D).
As the industry recovers from the COVID-19 pandemic, new opportunities and challenges are emerging. This article explores the current megatrends in MedTech R&D investment and identifies key growth opportunities that can shape the future of healthcare innovation.
Growth Perspectives: Key Highlights from the ESC Congress 2024 in London
The European Society of Cardiology (ESC) Congress 2024 event held in London during 30th August – 2nd September 2024, displayed groundbreaking analysis, practice-changing science and opportunities shaping the future of cardiovascular medicine. The event focused on personalizing cardiovascular care, with an emphasis on enhancing patient outcomes.
The Future of Healthcare Data Interoperability: Driving Seamless Data Exchange
The healthcare data interoperability landscape is undergoing rapid transformation, projected to reach $19.28 billion by 2028 with a robust 18.3% compound annual growth rate (CAGR).
This growth is fueled by regulatory pressures, changing care delivery models, and the need for seamless data exchange between various healthcare stakeholders. As interoperability solutions continue to evolve, they are becoming critical for improving patient care outcomes, operational efficiency, and data integration.
Dinesh Sampath Rangaraj (SVP & Global Client Leader at Frost & Sullivan) recently attended Medica Europe 2024 in Düsseldorf, where he explored major megatrends driving innovation in healthcare.
Some of his key observations from the event include:
- Shift to patient-centric care: This megatrend reflects the industry’s growing focus on more personalized, accessible, and compassionate care.
- AI and edge device integration: These advancements are set to revolutionize diagnostics and monitoring by making them more efficient, flexible, and cost-effective.
- Surgical and industrial robotics in healthcare: These technologies represent the healthcare sector’s ongoing embrace of automation, enhancing surgical precision, reducing recovery times, and improving patient outcomes.
With innovation as the overarching theme at Medica Europe, these advancements are paving the way for a smarter, more connected, and patient-focused healthcare system.
Medeze Group Awarded Frost & Sullivan’s 2024 Southeast Asia Company of the Year for Delivering Highly Innovative Stem Cell and Longevity Solutions
Frost & Sullivan analyzed the stem cell banking and longevity industry and, based on its findings, recognizes Medeze with the 2024 Southeast Asia Company of the Year Award. Medeze is a best-in-class provider of comprehensive stem cell banking services, offering solutions that significantly enhance longevity through sophisticated cryopreservation techniques and pioneering therapies.
Medeze has been a dominant player in Southeast Asia’s stem cell banking industry since its establishment in 2010. It has distinguished itself with a diverse portfolio that meets various medical demands, including autologous and allogeneic stem cell treatments for aesthetic concerns and therapeutic applications.
Novotech Awarded Frost & Sullivan’s 2024 Global Company of the Year Award for Its Leadership and Excellence in Biotech CRO Services
Frost & Sullivan conducted an in-depth analysis of the biotech contract research organization (CRO) industry and based on its findings, has awarded Novotech the 2024 Global Company of the Year Award. As a leading global full-service CRO with over 25 years of experience, Novotech specializes in providing comprehensive early- to late-phase clinical development services tailored to biotech companies.
Novotech enables biotech companies to navigate the complex global regulatory landscape by leveraging its extensive expertise in local regulations and deep understanding of cultural nuances.
LabVantage Solutions Applauded by Frost & Sullivan for Its Industry-leading Flexible, Scalable, and Cost-Effective LIMS Solutions
Frost & Sullivan assessed the laboratory information management systems (LIMS) industry and, based on its findings, recognizes LabVantage Solutions with the 2024 Global Company of the Year Award.
A leading provider of comprehensive laboratory (lab) informatics platforms, LabVantage Solutions offers differentiated, value-added solutions to transform data into knowledge and empower laboratories to address emerging business challenges and capitalize on future opportunities. The company helps customers streamline laboratory processes, manage data, and integrate systems to improve workflow efficiency.
Precision Health
Next-Generation Cardiometabolic Health: Strategic Partnerships for Precision-Driven Innovation
On-Demand
TechVision
Transforming Cancer Care: Cutting-Edge Innovations in Immuno-Oncology
On-Demand
On-demand Webinars
Discover a wide range of growth opportunities that can help you thrive amidst the transformation of precision health, chronic care, healthcare information technology, and women's health.
On-demand
Growth Processes
Explore the major growth opportunities impacting manufacturing, mergers and acquisitions, economy, strategy, vision, innovation, leadership, and more.
December 2024
—
Marriot Harbor Beach Resort and Spa, Fort Lauderdale, FL
A Frost & Sullivan MindXchange
—
Northeast Locale, USA
Embracing Generative AI Business Model Innovation
